SuperworthIDEAYA Biosciences market cap IDYA
Share price times shares outstanding: what the whole company sells for, since 2019.
- Today, Oct 23, 2026
- $3.3B
- Highest close in our data
- $3.9B
- Aug 2026
IDEAYA Biosciences is worth $3.3B at the close on Oct 23, 2026, at $34.71 a share.
That is up 31% over the last year and up 307% over five years.
Its highest close in our data was $3.9B in Aug 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $3.3B | $2.5B | $3.9B | +9% |
| 2025 | $3.1B | $1.3B | $3.1B | +42% |
| 2024 | $2.2B | $2.2B | $3.4B | −5% |
| 2023 | $2.3B | $664.4M | $2.3B | +162% |
| 2022 | $874.2M | $352.3M | $874.2M | −4% |
| 2021 | $910.1M | $406.7M | $1B | +124% |
| 2020 | $407M | $73M | $453.5M | +135% |
| 2019 | $172.8M | $108.4M | $186.2M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest IDEAYA Biosciences' size, closest first, today.
| Company | Market cap |
|---|---|
| IDYAIDEAYA Biosciences | $3.3B |
| OGNOrganon | $3.6B |
| LQDALiquidia | $3.8B |
| ARQTArcutis Biotherapeutics | $3.9B |
| NRIXNurix Therapeutics | $2.8B |
| INDVIndivior Pharmaceuticals | $4.1B |
| PBHPrestige Consumer Healthcare | $2.3B |
| HRMYHarmony Biosciences | $2.1B |
| KNSAKiniksa Pharmaceuticals International | $6B |
| LGNDLigand Pharmaceuticals | $6.1B |
| AMRXAmneal Pharmaceuticals | $6.5B |
| Peer median | $3.9B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on IDEAYA Biosciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.